Cargando…

Alpha(2) Antagonist Vatinoxan Does Not Abolish the Preconditioning Effect of Dexmedetomidine on Experimental Ischaemia–Reperfusion Injury in the Equine Small Intestine

SIMPLE SUMMARY: Intestinal disease with disruption of blood flow (ischaemia) is associated with a relatively high mortality rate in horses. Many investigations have focused on treatment strategies that reduce tissue injury. The sedative drug dexmedetomidine was found to precondition intestines subje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verhaar, Nicole, Kopp, Veronika, Pfarrer, Christiane, Neudeck, Stephan, König, Kathrin, Rohn, Karl, Kästner, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486550/ https://www.ncbi.nlm.nih.gov/pubmed/37685019 http://dx.doi.org/10.3390/ani13172755

Ejemplares similares

Ischaemic preconditioning and pharmacological preconditioning with dexmedetomidine in an equine model of small intestinal ischaemia-reperfusion
por: König, Kathrin S., et al.
Publicado: (2020)

Low Flow versus No Flow: Ischaemia Reperfusion Injury Following Different Experimental Models in the Equine Small Intestine
por: Grages, Anna Marei, et al.
Publicado: (2022)

Dexmedetomidine Has Differential Effects on the Contractility of Equine Jejunal Smooth Muscle Layers In Vitro
por: Verhaar, Nicole, et al.
Publicado: (2023)

Interpretations on Preconditioning with Lidocaine and Xylazine in Experimental Equine Jejunal Ischaemia
por: Sengul, Ilker, et al.
Publicado: (2020)

Ischaemic postconditioning reduces apoptosis in experimental jejunal ischaemia in horses
por: Verhaar, Nicole, et al.
Publicado: (2021)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

Hypoxia signaling in the equine small intestine: Expression and distribution of hypoxia inducible factors during experimental ischemia
por: Verhaar, Nicole, et al.
Publicado: (2023)

Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)

Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan
por: Pakkanen, Soile Anja Eliisa, et al.
Publicado: (2018)

An Evaluation of Ischaemic Preconditioning as a Method of Reducing Ischaemia Reperfusion Injury in Liver Surgery and Transplantation
por: Robertson, Francis P., et al.
Publicado: (2017)

Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats
por: Kip, Gülay, et al.
Publicado: (2015)

Effects of preconditioned plasma collected during the late phase of remote ischaemic preconditioning on ventricular arrhythmias caused by myocardial ischaemia reperfusion in rats
por: Zhao, Yang, et al.
Publicado: (2018)

Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant‐rate medetomidine infusion in standing horses
por: Tapio, H., et al.
Publicado: (2019)

Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media
por: Eydt, Carina, et al.
Publicado: (2016)

Jiaji (EX-B2)-Based Electroacupuncture Preconditioning Attenuates Early Ischaemia Reperfusion Injury in the Rat Myocardium
por: Xiao, Ning, et al.
Publicado: (2020)

Hypertrophic preconditioning cardioprotection after myocardial ischaemia/reperfusion injury involves ALDH2-dependent metabolism modulation
por: Ma, Lei-Lei, et al.
Publicado: (2021)

Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo
por: Weber, Bennet Y., et al.
Publicado: (2022)

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017)

Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients
por: Murphy, Terence, et al.
Publicado: (2010)

Protection against renal ischaemia/reperfusion injury: A comparative experimental study of the effect of ischaemic preconditioning vs. postconditioning
por: Shokeir, Ahmed A., et al.
Publicado: (2012)

Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR-24
por: Minghua, Wen, et al.
Publicado: (2018)

Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro
por: Schenning, Katie J, et al.
Publicado: (2015)

Effects of Dexmedetomidine Administered Through Different Routes on Kidney Tissue in Rats with Spinal Cord Ischaemia–Reperfusion Injury
por: Şengel, Necmiye, et al.
Publicado: (2022)

Hypertrophic Preconditioning Attenuates Myocardial Ischaemia‐Reperfusion Injury by Modulating SIRT3‐SOD2‐mROS‐Dependent Autophagy
por: Ma, Lei‐Lei, et al.
Publicado: (2021)

Cysteine hydropersulfide reduces lipid peroxidation and protects against myocardial ischaemia-reperfusion injury - Are endogenous persulfides mediators of ischaemic preconditioning?
por: Griffiths, Kayleigh, et al.
Publicado: (2023)

Acute Hyperglycemia Abolishes Ischemic Preconditioning by Inhibiting Akt Phosphorylation: Normalizing Blood Glucose before Ischemia Restores Ischemic Preconditioning
por: Yang, Zequan, et al.
Publicado: (2013)

Dexmedetomidine post‐treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF‐1α signalling
por: Peng, Ke, et al.
Publicado: (2019)

Dexmedetomidine reduces enteric glial cell injury induced by intestinal ischaemia‐reperfusion injury through mitochondrial localization of TERT
por: Hu, Qian, et al.
Publicado: (2022)

Dexmedetomidine for Prevention of Skeletal Muscle Ischaemia-Reperfusion Injury in Patients with Chronic Limb Ischaemia Undergoing Aortobifemoral Bypass Surgery: A Prospective Double-blind Randomized Controlled Study
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
por: Baidya, Raji, et al.
Publicado: (2020)

Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2021)

The effect of warm liver ischaemia & reperfusion injury on circulating plasma lipid levels & lipolytic enzyme activity in rat & the impact of ischaemic preconditioning
por: Lanitis, Sophocles, et al.
Publicado: (2012)

Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis
por: Wu, Xiaomei, et al.
Publicado: (2009)

Dexmedetomidine alleviates hepatic ischaemia‐reperfusion injury via the PI3K/AKT/Nrf2‐NLRP3 pathway
por: Wu, Yan, et al.
Publicado: (2021)

Dexmedetomidine Preconditioning Attenuates Cisplatin-Induced Ototoxicity in Zebrafish
por: Min, Too Jae, et al.
Publicado: (2014)

Hypoxia-preconditioned olfactory mucosa mesenchymal stem cells abolish cerebral ischemia/reperfusion-induced pyroptosis and apoptotic death of microglial cells by activating HIF-1α
por: Huang, Yan, et al.
Publicado: (2020)

Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury
por: Martin, Jack L., et al.
Publicado: (2018)

Correction to: Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2022)

Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia‐reperfusion injury by targeting the CNPY2‐endoplasmic reticulum stress signalling
por: Zhao, Lina, et al.
Publicado: (2019)

Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury
por: Li, Hui-xian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7vv93h0gud54n6e3mc7n0ja0k